Torrent Pharma:

Sushil Finance has recommended hold rating on Torrent Pharma (TPL) with a target price of Rs 739, in its February 08, 2013 research report.

"Torrent Pharma (TPL) has reported decent set of numbers which are above our estimates for Q3FY13 registering a YoY revenue growth of 14.5% majorly supported by a 14.2% growth in international business and a 12.5% growth in the domestic market. However, EBIDTA grew by 32.6% on the back of a forex gain coupled with a licensing & litigation fee received during the quarter.

Gateway Distriparks:

SPA Research is bullish on Gateway Distriparks (GDL) and has recommended buy rating on the stock with a target price of Rs 223 in its February 08, 2013 research report.

"Gateway Distriparks (GDL) reported disappointing set of numbers in Q3FY13. Company registered revenue and PAT lower than our expectations on the back of falling throughput in Mumbai CFS and continuous pressure on margins in CFS and rail business. Consolidated revenues at INR 2,384mn grew by 22% YoY while PAT registered a de-growth of 15% YoY to INR 280mn.

Maharashtra Seamless:

Dolat Capital is bullish on Maharashtra Seamless and has recommended accumulate rating on the stock with a target price of Rs 255 in its February 08, 2013 research report.

"Maharashtra Seamless, net sales declined by 36.6%YoY/18.5%QoQ to Rs 3.91bn (DCe: Rs 5.34bn) primarily due to lower volumes. Sales volumes in seamless pipes at 46466 tonne (-17.3%QoQ/-34.5%YoY) and ERW pipes at 18386 tonnes (-45.5%QoQ,/ -7.7%YoY) were weak in both the segments.

Mahindra Holidays:

Ventura Securities is bullish on Mahindra Holidays and Resorts India (MHRIL) and has recommended buy rating on the stock with a target price of Rs 437 in its February 07, 2013 research report.

"MHRIL reported a decent revenue growth of 19.3% YoY to Rs 172.4 crore in Q3FY13 as against Rs 144.5 crore in Q3FY12 on the back of improved average realisations (from Rs 3.4 lacs to Rs 3.8 lacs; +11.8% QoQ). The realisations improved on account of improved product mix which resulted due to company's conscious decision to stop selling "Zest" during the quarter. The company reported 17.6% and 13.7% growth in EBITDA and PAT at Rs 46.8 crore and Rs 30.1 crore respectively.

GoodReturns.in

DISCLAIMER: GoodReturns provides you with information covering shares, futures and options based on broker's reports as stated on various media. Investors are, however, warned that they should NOT take any buy or sell decision based on these views expressed in the article. Investors should consult their own financial and share advisors before taking purchase or sale decisions. GoodReturns does not take any responsibility for any losses incurred by investors who take their cues from the above article.